Adverse drug reactions in elderly patients

British Journal of Clinical Pharmacology

Volumn 57, Issue 2, 2004, Pages 121-126

  Routledge, P A ^a   O'Mahony, M S ^a   Woodhouse, K W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adverse drug reactions; Ageing; Drug prescribing

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; BENOXAPROFEN; CARDIOVASCULAR AGENT; CORTICOSTEROID; FLUOROURACIL; NONSTEROID ANTIINFLAMMATORY AGENT;

COMPUTER SYSTEM; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; ELDERLY CARE; HOSPITAL ADMISSION; HUMAN; LIVER TOXICITY; PEPTIC ULCER; PHOTOSENSITIVITY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TREATMENT FAILURE; TYPE A SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; DRUG INTERACTIONS; HUMANS; INTERPROFESSIONAL RELATIONS; PHARMACEUTICAL PREPARATIONS; PHARMACY;

EID: 1242306685     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01875.x     Document Type: Review

References (53)

1. Cunningham G, Dodd TRP, Grant DJ, Murdo MET, Richards RME. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375-82.
2. Mannesse CK, Derkx FH, de Ridder MA, Man in 't Veld AJ, van der Cammen TJ. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. Br Med J 1997; 315: 1057-8.
3. Mannesse CK, Derkx FH, de Ridder MA, Man in 't Veld AJ, van der Cammen TJ. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35-9.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
5. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. Bandolier Extra 2002; 1-15 http://www. bandolier.com
6. Anon. A spoonful of sugar; medicines management in NHS hospitals. London: Audit Commission, 2001.
7. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114: 956-66.
8. Cooper JW. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatric Soc 1996; 44: 194-7.
9. Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980; 9: 73-80.
10. Davidsen F, Haghfelt T, Gram LF, Brosen K. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol 1988; 34: 83-6.
11. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093-9.
12. Lassila HC, Stoehr GP, Ganguli M et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother 1996; 30: 589-95.
13. Straand J, Rokstad KS. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. A report from the More & Romsdal Prescription Study. Fam Pract 1999; 16: 380-8.
14. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236-40.
15. Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 2001; 6: 935-41.
16. Dormann H, Krebs S, Muth-Selbach U et al. Adverse drug reactions in patients with gastroenterological diseases: does age increase the risk? Aliment Pharmacol Ther 2001; 15: 171-80.
17. Rawlins MD, Thompson JP. Pathogenesis of adverse drug reactions. In Textbook of adverse drug reactions, ed Davies DM. Oxford: Oxford University Press, 1977; 44.
18. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-8.
19. Lagnaouie R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 56: 181-6.
20. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000; 25: 355-61.
21. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331-6.
22. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
23. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000; 34: 1373-9.
24. Bowman L, Carlstedt BC, Hancock EF, Black CD. Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Saf 1996; 5: 9-18.
25. Olsson R, Wiholm BE, Sand C, Zettergren L, Hultcrantz R, Myrhed M. Liver damage from flucloxacillin, cloxacillin, and dicloxacillin. J Hepatol 1992; 15: 151-4.
26. Devereaux BM, Crawford DH, Purcell P, Powell LW, Roeser HP. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic? Eur J Clin Pharmacol 1995; 49: 81-5.
27. Larrey D, Vial T, Micaleff A et al. Hepatitis associated with amoxycillin-clavulanic acid combination: report of 15 cases. Gut 1992; 33: 368-71.
28. O'Mahony MS, Woodhouse KW. Age, environmental factors and drug metabolism. Pharmacol Ther 1994; 61: 279-87.
29. Routledge PA. Therapeutics and toxicology. In Textbook of medicine, 4th edn, eds Souhami RL, Moxham J. Edinburgh: Churchill Livingstone, 2002.
30. Lackner TE. Strategies for optimizing antiepileptic drug therapy in elderly people. Pharmacotherapy 2002; 22: 329-64.
31. Nobili A, Tettamanti M, Frattura L et al. Drug use by the elderly in Italy. Ann Pharmacother 1997; 31: 416-22.
32. Onder C, Pedone C, Landi F et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-8.
33. Stewart RB, Cooper JW. Polypharmacy in the aged. Practical solutions. Drugs Aging 1994; 4: 449-61.
34. Hudson RP. Polypharmacy in twentieth century America. Clin Pharmacol Ther 1968; 9: 2-10.
35. Hogerzeil HV. Promoting rational prescribing: an international perspective. Br J Clin Pharmacol 1995; 39: 1-6.
36. Willmore LJ. Management of epilepsy in the elderly. Epilepsia 1996; 37 (Suppl 6): S23-33.
37. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.
38. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114: 735-40.
39. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153: 1665-70.
40. Halsey JP, Cardoe N. Benoxaprofen: side-effect profile in 300 patients. Br Med J 1982; 284: 1365-8.
41. Bedell SE, Jabbour S, Goldberg R et al. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med 2000; 160: 2129-34.
42. Atkin PA, Veitch PC, Veitch EM, Ogle SJ. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14: 141-52.
43. Seymour RM, Routledge PA. Important drug-drug interactions in the elderly. Drugs Aging 1998; 12: 485-94.
44. Routledge PA, Hutchings AD. Therapeutic Drug Monitoring (TDM). In The immunoassay handbook, 2nd edn. ed Wild D. London: Nature Publishing Group, 2001.
45. Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy 1998; 18: 1112-20.
46. Tamblyn RM, McLeod PJ, Abrahamowicz M et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996; 154: 1174-84.
47. Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health Syst Pharm 1999; 56: 1524-9.
48. Shorr RI, Bauwens SF. Effects of patient age and physician training on choice and dose of benzodiazepine hypnotic drugs. Arch Intern Med 1990; 150: 293-5.
49. Levy AR, Tamblyn RM, Mcleod PJ, Fitchett D, Abrahamowicz M. The effect of physicians' training on prescribing beta-blockers for secondary prevention of myocardial infarction in the elderly. Ann Epidemiol 2002; 12: 86-9.
50. Anonymous. Reducing and preventing adverse drug events to decrease hospital costs. Rockville, MD: Agency for Healthcare Research and Quality, 2000.
51. Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes. A systematic review. JAMA 1998; 280: 1339-46.
52. Raschetti R, Morgutti M, Menniti Ippolito F et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959-63.
53. Martin U, George CF. Drugs and the elderly. In Pharmacovigilance, eds Mann R, Andrews E. Chichester: Wiley, 2002.